跳至主要内容
临床试验/CTRI/2021/04/033101
CTRI/2021/04/033101已完成3 期

A Prospective, Randomized, Open Label Study to Evaluate the Safety And Efficacy Of Mulmina Orange Amla Ready to Drink as a Supplement In Women With PCOS

Jagdale industries pvt Ltd0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • i.Female volunteer aged more than 18 years
  • ii.Women with mild PCOS related complications
  • iii.Willing to give written consent to participate

排除标准

  • 1.Patients with preexisting severe systemic disease necessitating long term medication.
  • 2.Patients with known history of diabetes mellitus.
  • 3.Evidence of significant uncontrolled comorbid disease which in the investigators opinion would jeopardize patient participation.
  • 4.History of cancer including solid tumors hematologic malignancies and carcinoma in situ
  • 5.Any neurological congenital or acquired vascular or systemic disorder which could affect any of the efficacy assessments.
  • 6.Participation in the current or previous treatment with any approved or investigational health supplements during the past 1 month.

研究者

相似试验